A Swine In-vivo Liver Model for Morphometric Characterization of Radiofrequency Thermal Ablation-induced Necrosis

2020 ◽  
Vol 174 ◽  
pp. 180
Author(s):  
P. Pregel ◽  
M. Bullone ◽  
M. Martano ◽  
L. Nozza ◽  
L. Starvaggi Cucuzza ◽  
...  
2004 ◽  
Vol 183 (3) ◽  
pp. 599-603 ◽  
Author(s):  
Frank K. Wacker ◽  
Sherif G. Nour ◽  
Rosana Eisenberg ◽  
Jeffrey L. Duerk ◽  
Jonathan S. Lewin

1981 ◽  
Vol 21 (3) ◽  
pp. 320-331 ◽  
Author(s):  
Carlos A. Ramírez ◽  
Michael B. Stemerman ◽  
Kenneth A. Isaacson ◽  
Clark K. Colton ◽  
Kenneth A. Smith ◽  
...  

2017 ◽  
Vol 2 (2) ◽  
pp. 125-130 ◽  
Author(s):  
Janis L. Vahldiek ◽  
Stefan F. Thieme ◽  
Ole Gemeinhardt ◽  
Franz Poch ◽  
Bernhard Hiebl ◽  
...  

2020 ◽  
Vol 477 (7) ◽  
pp. 1261-1286 ◽  
Author(s):  
Marie Anne Richard ◽  
Hannah Pallubinsky ◽  
Denis P. Blondin

Brown adipose tissue (BAT) has long been described according to its histological features as a multilocular, lipid-containing tissue, light brown in color, that is also responsive to the cold and found especially in hibernating mammals and human infants. Its presence in both hibernators and human infants, combined with its function as a heat-generating organ, raised many questions about its role in humans. Early characterizations of the tissue in humans focused on its progressive atrophy with age and its apparent importance for cold-exposed workers. However, the use of positron emission tomography (PET) with the glucose tracer [18F]fluorodeoxyglucose ([18F]FDG) made it possible to begin characterizing the possible function of BAT in adult humans, and whether it could play a role in the prevention or treatment of obesity and type 2 diabetes (T2D). This review focuses on the in vivo functional characterization of human BAT, the methodological approaches applied to examine these features and addresses critical gaps that remain in moving the field forward. Specifically, we describe the anatomical and biomolecular features of human BAT, the modalities and applications of non-invasive tools such as PET and magnetic resonance imaging coupled with spectroscopy (MRI/MRS) to study BAT morphology and function in vivo, and finally describe the functional characteristics of human BAT that have only been possible through the development and application of such tools.


2007 ◽  
Vol 177 (4S) ◽  
pp. 210-211 ◽  
Author(s):  
Joshua M. Stern ◽  
Jennifer Stanfield ◽  
Jer-Tsang Hsieh ◽  
Jeffrey A. Cadeddu

1995 ◽  
Vol 74 (02) ◽  
pp. 673-679 ◽  
Author(s):  
C E Dempfle ◽  
S A Pfitzner ◽  
M Dollman ◽  
K Huck ◽  
G Stehle ◽  
...  

SummaryVarious assays have been developed for quantitation of soluble fibrin or fibrin monomer in clinical plasma samples, since this parameter directly reflects in vivo thrombin action on fibrinogen. Using plasma samples from healthy blood donors, patients with cerebral ischemic insult, patients with septicemia, and patients with venous thrombosis, we compared two immunologic tests using monoclonal antibodies against fibrin-specific neo-epitopes, and two functional tests based on the cofactor activity of soluble fibrin complexes in tPA-induced plasminogen activation. Test A (Enzymun®-Test FM) showed the best discriminating power among normal range and pathological samples. Test B (Fibrinostika® soluble fibrin) clearly separated normal range from pathological samples, but failed to discriminate among samples from patients with low grade coagulation activation in septicemia, and massive activation in venous thrombosis. Functional test C (Fibrin monomer test Behring) displayed good discriminating power between normal and pathological range samples, and correlated with test A (r = 0.61), whereas assay D (Coa-Set® Fibrin monomer) showed little discriminating power at values below 10 μg/ml and little correlation with other assays. Standardization of assays will require further characterization of analytes detected.


Sign in / Sign up

Export Citation Format

Share Document